UBS Group AG - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$85,223
+23.5%
35,808
-8.7%
0.00%
Q2 2023$69,020
+86.5%
39,216
+226.4%
0.00%
Q1 2023$37,000
+67.3%
12,013
+187.9%
0.00%
Q4 2022$22,117
-67.0%
4,173
-57.4%
0.00%
Q4 2021$67,000
+235.0%
9,795
+389.8%
0.00%
Q2 2021$20,000
-98.2%
2,000
-98.3%
0.00%
Q1 2021$1,125,000
-5.1%
117,782
+9.0%
0.00%
Q4 2020$1,186,000
+26.0%
108,076
+1.9%
0.00%
Q3 2020$941,000106,0850.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders